Gram-Positive Bacterial Infections Therapeutics- Pipeline Analysis 2018

Press Release

Gram-positive bacterial infections are caused by gram-positive bacteria, such as Staphylococcus aureus and Enterococcus spp. This infection sometimes become fatal in the immune-compromised person, and it is generally found in new-born.

Download the sample report @ https://www.pharmaproff.com/request-sample/1060

The infection when contracted during pregnancy can cause chorioamnionitis and postpartum infections. Further, urinary tract infections associated with the bacteria can also cause premature birth.

Get the detailed analysis @ https://www.pharmaproff.com/report/gram-positive-bacterial-infections-therapeutics-pipeline-analysis

Some of the characteristics of gram-positive bacteria are thick peptidoglycan layer, presence of teichoic acids, DD-transpeptidase for cross-linking in the cell walls, and cytoplasmic lipid membrane. Gram-positive bacteria give positive result in gram stain test.

Make enquiry before purchase @  https://www.pharmaproff.com/enquiry/1060

Merck & Co. Inc. is in the process of developing tedizolid phosphate for the treatment of gram-positive bacterial infections. Pfizer Inc. is also involved in the pipeline for Gram-positive bacterial infections.

  • The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
  • Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: [email protected]

Web: https://www.pharmaproff.com